QUALITY ASSESSMENT AND ASSURANCE OF TEMCELL<sup>TM</sup>, A CELLULAR THERAPY PRODUCT-Reference-Cited by-同舟云学术

QUALITY ASSESSMENT AND ASSURANCE OF TEMCELL^TM, A CELLULAR THERAPY PRODUCT

Published:2020-02-25 Issue:1 Volume:66 Page:27-30
ISSN:1881-3011
Container-title:Japanese Journal of Transfusion and Cell Therapy
language:en
Short-container-title:JJTC

Author:

Sugiyama Hiroki¹,Ikemoto Junko¹,Yoshihara Satoshi¹²,Yamamoto Nao¹,Ohno Mayuko¹,Harada Yuki¹,Otsuka Shinya¹,Onomoto Hitomi¹,Murata Rie¹,Maeda Kazuhiro¹,Okuda Noriko¹,Yoshihara Kyoko¹²,Yamahara Kenichi¹²,Okada Masaya²,Fujimori Yoshihiro¹²

Affiliation:

1. Department of Transfusion Medicine and Cellular Therapy, Hyogo College of Medicine

2. Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

https://www.jstage.jst.go.jp/article/jjtc/66/1/66_27/_pdf

Reference7 articles.

1. 1) Le Blanc K, Rasmusson I, Sundberg B, et al: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363: 1439-1441, 2004.

2. 2) Le Blanc K, Frassoni F, Ball L, et al: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet, 371: 1579-1586, 2008.

3. 3) Kebriaei P, Isola L, Bahceci E, et al: Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant, 15: 804-811, 2009.

4. 4) Muroi K, Miyamura K, Ohashi K, et al: Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study. Int J Hematol, 98: 206-213, 2013.

5. 5) Muroi K, Miyamura K, Okada M, et al: Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study. Int J Hematol, 103: 243-250, 2016.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SURVEY OF INSTITUTIONAL HANDLING OF REGENERATIVE MEDICAL PRODUCTS CONDUCTED BY THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY IN 2022;Japanese Journal of Transfusion and Cell Therapy;2024-02-26